Pyelonephritis Drug Market, Global Outlook and Forecast 2022-2028

Pyelonephritis Drug Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281663 | No. of Pages: 72 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Pyelonephritis Drug in global, including the following market information:
Global Pyelonephritis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pyelonephritis Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pyelonephritis Drug companies in 2021 (%)
The global Pyelonephritis Drug market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Finafloxacin Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pyelonephritis Drug include Achaogen Inc, AstraZeneca Plc, Meiji Seika Pharma Co Ltd, Merck & Co Inc, MerLion Pharmaceuticals Pte Ltd, The Medicines Company and Zavante Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pyelonephritis Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pyelonephritis Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pyelonephritis Drug Market Segment Percentages, by Type, 2021 (%)
    Finafloxacin
    Fosfomycin Tromethamine
    Nacubactam
    Plazomicin Sulfate
    Others
Global Pyelonephritis Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pyelonephritis Drug Market Segment Percentages, by Application, 2021 (%)
    Hospital
    Clinic
    Others
Global Pyelonephritis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pyelonephritis Drug Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pyelonephritis Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pyelonephritis Drug revenues share in global market, 2021 (%)
Key companies Pyelonephritis Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pyelonephritis Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Achaogen Inc
    AstraZeneca Plc
    Meiji Seika Pharma Co Ltd
    Merck & Co Inc
    MerLion Pharmaceuticals Pte Ltd
    The Medicines Company
    Zavante Therapeutics Inc
1 Introduction to Research & Analysis Reports
    1.1 Pyelonephritis Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pyelonephritis Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pyelonephritis Drug Overall Market Size
    2.1 Global Pyelonephritis Drug Market Size: 2021 VS 2028
    2.2 Global Pyelonephritis Drug Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Pyelonephritis Drug Sales: 2017-2028
3 Company Landscape
    3.1 Top Pyelonephritis Drug Players in Global Market
    3.2 Top Global Pyelonephritis Drug Companies Ranked by Revenue
    3.3 Global Pyelonephritis Drug Revenue by Companies
    3.4 Global Pyelonephritis Drug Sales by Companies
    3.5 Global Pyelonephritis Drug Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Pyelonephritis Drug Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Pyelonephritis Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Pyelonephritis Drug Players in Global Market
        3.8.1 List of Global Tier 1 Pyelonephritis Drug Companies
        3.8.2 List of Global Tier 2 and Tier 3 Pyelonephritis Drug Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pyelonephritis Drug Market Size Markets, 2021 & 2028
        4.1.2 Finafloxacin
        4.1.3 Fosfomycin Tromethamine
        4.1.4 Nacubactam
        4.1.5 Plazomicin Sulfate
        4.1.6 Others
    4.2 By Type - Global Pyelonephritis Drug Revenue & Forecasts
        4.2.1 By Type - Global Pyelonephritis Drug Revenue, 2017-2022
        4.2.2 By Type - Global Pyelonephritis Drug Revenue, 2023-2028
        4.2.3 By Type - Global Pyelonephritis Drug Revenue Market Share, 2017-2028
    4.3 By Type - Global Pyelonephritis Drug Sales & Forecasts
        4.3.1 By Type - Global Pyelonephritis Drug Sales, 2017-2022
        4.3.2 By Type - Global Pyelonephritis Drug Sales, 2023-2028
        4.3.3 By Type - Global Pyelonephritis Drug Sales Market Share, 2017-2028
    4.4 By Type - Global Pyelonephritis Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Pyelonephritis Drug Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Pyelonephritis Drug Revenue & Forecasts
        5.2.1 By Application - Global Pyelonephritis Drug Revenue, 2017-2022
        5.2.2 By Application - Global Pyelonephritis Drug Revenue, 2023-2028
        5.2.3 By Application - Global Pyelonephritis Drug Revenue Market Share, 2017-2028
    5.3 By Application - Global Pyelonephritis Drug Sales & Forecasts
        5.3.1 By Application - Global Pyelonephritis Drug Sales, 2017-2022
        5.3.2 By Application - Global Pyelonephritis Drug Sales, 2023-2028
        5.3.3 By Application - Global Pyelonephritis Drug Sales Market Share, 2017-2028
    5.4 By Application - Global Pyelonephritis Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Pyelonephritis Drug Market Size, 2021 & 2028
    6.2 By Region - Global Pyelonephritis Drug Revenue & Forecasts
        6.2.1 By Region - Global Pyelonephritis Drug Revenue, 2017-2022
        6.2.2 By Region - Global Pyelonephritis Drug Revenue, 2023-2028
        6.2.3 By Region - Global Pyelonephritis Drug Revenue Market Share, 2017-2028
    6.3 By Region - Global Pyelonephritis Drug Sales & Forecasts
        6.3.1 By Region - Global Pyelonephritis Drug Sales, 2017-2022
        6.3.2 By Region - Global Pyelonephritis Drug Sales, 2023-2028
        6.3.3 By Region - Global Pyelonephritis Drug Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Pyelonephritis Drug Revenue, 2017-2028
        6.4.2 By Country - North America Pyelonephritis Drug Sales, 2017-2028
        6.4.3 US Pyelonephritis Drug Market Size, 2017-2028
        6.4.4 Canada Pyelonephritis Drug Market Size, 2017-2028
        6.4.5 Mexico Pyelonephritis Drug Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Pyelonephritis Drug Revenue, 2017-2028
        6.5.2 By Country - Europe Pyelonephritis Drug Sales, 2017-2028
        6.5.3 Germany Pyelonephritis Drug Market Size, 2017-2028
        6.5.4 France Pyelonephritis Drug Market Size, 2017-2028
        6.5.5 U.K. Pyelonephritis Drug Market Size, 2017-2028
        6.5.6 Italy Pyelonephritis Drug Market Size, 2017-2028
        6.5.7 Russia Pyelonephritis Drug Market Size, 2017-2028
        6.5.8 Nordic Countries Pyelonephritis Drug Market Size, 2017-2028
        6.5.9 Benelux Pyelonephritis Drug Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Pyelonephritis Drug Revenue, 2017-2028
        6.6.2 By Region - Asia Pyelonephritis Drug Sales, 2017-2028
        6.6.3 China Pyelonephritis Drug Market Size, 2017-2028
        6.6.4 Japan Pyelonephritis Drug Market Size, 2017-2028
        6.6.5 South Korea Pyelonephritis Drug Market Size, 2017-2028
        6.6.6 Southeast Asia Pyelonephritis Drug Market Size, 2017-2028
        6.6.7 India Pyelonephritis Drug Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Pyelonephritis Drug Revenue, 2017-2028
        6.7.2 By Country - South America Pyelonephritis Drug Sales, 2017-2028
        6.7.3 Brazil Pyelonephritis Drug Market Size, 2017-2028
        6.7.4 Argentina Pyelonephritis Drug Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Pyelonephritis Drug Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Pyelonephritis Drug Sales, 2017-2028
        6.8.3 Turkey Pyelonephritis Drug Market Size, 2017-2028
        6.8.4 Israel Pyelonephritis Drug Market Size, 2017-2028
        6.8.5 Saudi Arabia Pyelonephritis Drug Market Size, 2017-2028
        6.8.6 UAE Pyelonephritis Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Achaogen Inc
        7.1.1 Achaogen Inc Corporate Summary
        7.1.2 Achaogen Inc Business Overview
        7.1.3 Achaogen Inc Pyelonephritis Drug Major Product Offerings
        7.1.4 Achaogen Inc Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.1.5 Achaogen Inc Key News
    7.2 AstraZeneca Plc
        7.2.1 AstraZeneca Plc Corporate Summary
        7.2.2 AstraZeneca Plc Business Overview
        7.2.3 AstraZeneca Plc Pyelonephritis Drug Major Product Offerings
        7.2.4 AstraZeneca Plc Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.2.5 AstraZeneca Plc Key News
    7.3 Meiji Seika Pharma Co Ltd
        7.3.1 Meiji Seika Pharma Co Ltd Corporate Summary
        7.3.2 Meiji Seika Pharma Co Ltd Business Overview
        7.3.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Major Product Offerings
        7.3.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.3.5 Meiji Seika Pharma Co Ltd Key News
    7.4 Merck & Co Inc
        7.4.1 Merck & Co Inc Corporate Summary
        7.4.2 Merck & Co Inc Business Overview
        7.4.3 Merck & Co Inc Pyelonephritis Drug Major Product Offerings
        7.4.4 Merck & Co Inc Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.4.5 Merck & Co Inc Key News
    7.5 MerLion Pharmaceuticals Pte Ltd
        7.5.1 MerLion Pharmaceuticals Pte Ltd Corporate Summary
        7.5.2 MerLion Pharmaceuticals Pte Ltd Business Overview
        7.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Major Product Offerings
        7.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.5.5 MerLion Pharmaceuticals Pte Ltd Key News
    7.6 The Medicines Company
        7.6.1 The Medicines Company Corporate Summary
        7.6.2 The Medicines Company Business Overview
        7.6.3 The Medicines Company Pyelonephritis Drug Major Product Offerings
        7.6.4 The Medicines Company Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.6.5 The Medicines Company Key News
    7.7 Zavante Therapeutics Inc
        7.7.1 Zavante Therapeutics Inc Corporate Summary
        7.7.2 Zavante Therapeutics Inc Business Overview
        7.7.3 Zavante Therapeutics Inc Pyelonephritis Drug Major Product Offerings
        7.7.4 Zavante Therapeutics Inc Pyelonephritis Drug Sales and Revenue in Global (2017-2022)
        7.7.5 Zavante Therapeutics Inc Key News
8 Global Pyelonephritis Drug Production Capacity, Analysis
    8.1 Global Pyelonephritis Drug Production Capacity, 2017-2028
    8.2 Pyelonephritis Drug Production Capacity of Key Manufacturers in Global Market
    8.3 Global Pyelonephritis Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Pyelonephritis Drug Supply Chain Analysis
    10.1 Pyelonephritis Drug Industry Value Chain
    10.2 Pyelonephritis Drug Upstream Market
    10.3 Pyelonephritis Drug Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Pyelonephritis Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com